These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24781423)

  • 61. Day two post retrieval 1500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger - a proof of concept study.
    Vanetik S; Segal L; Breizman T; Kol S
    Gynecol Endocrinol; 2018 Feb; 34(2):132-135. PubMed ID: 28933569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.
    Qiao J; Lu G; Zhang HW; Chen H; Ma C; Olofsson JI; Witjes H; Heijnen E; Mannaerts B
    Gynecol Endocrinol; 2012 Oct; 28(10):800-4. PubMed ID: 22429192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can FSH co-trigger prevent OHSS?
    Rosen MP; Meldrum DR
    Fertil Steril; 2012 Mar; 97(3):534-5. PubMed ID: 22285746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.
    Ozmen B; Sükür YE; Seval MM; Ateş C; Atabekoğlu CS; Sönmezer M; Berker B
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():137-40. PubMed ID: 25461367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study.
    Muñoz M; Cruz M; Humaidan P; Garrido N; Pérez-Cano I; Meseguer M
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):167-72. PubMed ID: 23351671
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Hudson C
    Fertil Steril; 2011 Jun; 95(8):2715-7. PubMed ID: 21550042
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is multiple pregnancy an unavoidable complication of ovulation induction? The case for pulsatile GnRH.
    Filicori M; Cognigni GE; Arnone R; Carbone F; Falbo A; Tabarelli C; Pari C; Ciampaglia W; Casadio P; Spettoli D; Pecorari R
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65 Suppl():S19-21. PubMed ID: 8735007
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collected.
    Ata B; Seyhan A; Polat M; Young Son W; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2595. PubMed ID: 23838158
    [No Abstract]   [Full Text] [Related]  

  • 75. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee.
    Nardo LG; Bosch E; Lambalk CB; Gelbaya TA
    Hum Fertil (Camb); 2013 Sep; 16(3):144-50. PubMed ID: 23705667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
    Filicori M
    Fertil Steril; 2014 Apr; 101(4):936-7. PubMed ID: 24613536
    [No Abstract]   [Full Text] [Related]  

  • 78. Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
    Wu TC; Gelety TJ; Jih MH; Fournet N; Buyalos R
    J Assist Reprod Genet; 1992 Jun; 9(3):281-3. PubMed ID: 1525462
    [No Abstract]   [Full Text] [Related]  

  • 79. The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation.
    Homburg R; Ben-Rafael Z
    J Assist Reprod Genet; 1996 May; 13(5):371-3. PubMed ID: 8739050
    [No Abstract]   [Full Text] [Related]  

  • 80. Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome.
    Yoshii F; Ooki N; Shinohara Y; Uehara K; Mochimaru F
    Neurology; 1999 Jul; 53(1):225-7. PubMed ID: 10408568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.